検索結果

roval of this Product enables us to offer a new treatment option that addresses these unmet medical needs. We sincerely hope that Avarept® will help improve DED symptoms and enhance the Quality of lif...

ugs to treat a disease affecting less than 50,000 patients in Japan, with particularly high medical needs. This designation can be expected to shorten the period required for regulatory approval, resu...

ugs to treat a disease affecting less than 50,000 patients in Japan, with particularly high medical needs. This designation can be expected to shorten the period required for regulatory approval, resu...

Supplement business | Business Activities | About Senju | SENJU Pharmaceutical

ry day. In the Supplement business, we will provide wellness items that are considerate of people’s needs and free of pharmaceutical products.

Product Development Policy | Research & Development | SENJU Pharmaceutica

bution of the diseases to visual impairment or blindness," "satisfaction of unmet medical needs*," and "possibility of commercialization." We have mainly developed ethical dru...